Intuitive Surgical, Inc. $ISRG Stock: BDF Gestion Reduces Holdings

BDF Gestion lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 55.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,354 shares of the medical equipment provider’s stock after selling 6,715 shares during the period. BDF Gestion’s holdings in Intuitive Surgical were worth $2,177,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the stock. Main Street Group LTD bought a new stake in Intuitive Surgical during the first quarter worth $30,000. North Point Portfolio Managers Corp OH purchased a new stake in shares of Intuitive Surgical during the third quarter worth $27,000. Vermillion Wealth Management Inc. boosted its holdings in shares of Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 25 shares during the period. Evergreen Advisors LLC purchased a new position in shares of Intuitive Surgical in the first quarter valued at $35,000. Finally, Compass Financial Management LLC purchased a new position in shares of Intuitive Surgical in the second quarter valued at $30,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 72 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total value of $28,303.20. Following the transaction, the director owned 179 shares of the company’s stock, valued at $70,364.90. This represents a 28.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the transaction, the director directly owned 1,245,679 shares in the company, valued at $498,271,600. The trade was a 0.80% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock valued at $4,891,989 over the last three months. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $5.38 during midday trading on Monday, hitting $432.08. 1,191,230 shares of the company’s stock were exchanged, compared to its average volume of 2,403,120. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock has a 50-day moving average price of $391.43 and a two-hundred day moving average price of $409.44. The company has a market cap of $152.65 billion, a P/E ratio of 49.53, a PEG ratio of 3.22 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The firm had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter last year, the firm posted $1.81 EPS. The company’s revenue was up 18.4% compared to the same quarter last year. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Truist Financial decreased their price objective on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research note on Thursday, July 16th. Raymond James Financial restated an “outperform” rating and issued a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. TD Cowen reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Monday. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Finally, Stifel Nicolaus lowered their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a report on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $498.83.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.